Cargando…
DDRE-02. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA
BACKGROUND: Medulloblastoma is an aggressive pediatric brain tumor that is associated with misactivation of the Hedgehog (HH) pathway. Our lab has shown that CDK6, a critical activator of the cell cycle, is a direct transcriptional target of oncogenic HH signaling, and that inhibiting CDK6 blocks th...
Autores principales: | Daggubati, Vikas, Hochstelter, Jordan, Bommireddy, Ani, Choudhury, Abrar, Krup, Alexis, Kaur, Pervinder, Tong, Pakteema, Li, Amy, Xu, Libin, Reiter, Jeremy, Raleigh, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992202/ http://dx.doi.org/10.1093/noajnl/vdab024.024 |
Ejemplares similares
-
EMBR-16. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA
por: Daggubati, Vikas, et al.
Publicado: (2021) -
Hedgehog target genes regulate lipid metabolism to drive basal cell carcinoma and medulloblastoma
por: Daggubati, Vikas, et al.
Publicado: (2023) -
Sterol and oxysterol synthases near the ciliary base activate the Hedgehog pathway
por: Findakly, Sarah, et al.
Publicado: (2020) -
Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma
por: Pereira, Victor, et al.
Publicado: (2021) -
DDRE-34. TARGETING RESISTANCE IN MEDULLOBLASTOMA
por: Chang, Simone, et al.
Publicado: (2021)